Selected research
Industry Research
Hydroxyprogesterone Caproate Industry Research Report 2026
Market perspective
The global Hydroxyprogesterone Caproate market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Hydroxyprogesterone Caproate is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Hydroxyprogesterone Caproate is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Hydroxyprogesterone Caproate is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Hydroxyprogesterone Caproate include Zhejiang Xianju Pharmaceutical, Mylan Institutional, Upjohn Co, Symbiotec Pharmalab, Sun Pharmaceutical, Steroid Spa, Schering Ag, Naari Ag and Mcguff Pharmaceuticals Inc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Hydroxyprogesterone Caproate market in terms of revenue (US$ million) and, where applicable, sales volume (W Tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/W Tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Hydroxyprogesterone Caproate Market by Company
Zhejiang Xianju Pharmaceutical
Mylan Institutional
Upjohn Co
Symbiotec Pharmalab
Sun Pharmaceutical
Steroid Spa
Schering Ag
Naari Ag
Mcguff Pharmaceuticals Inc
Diosynth Bv
Aspen Oss B.V.
Antibioticos Spa
ANI Pharmaceuticals, Inc.
AMAG Pharmaceuticals
Hydroxyprogesterone Caproate Segment by Type
1 mL Injection(Including 1.1 mL)
5 mL Injection
Hydroxyprogesterone Caproate Segment by Application
Hospitals Injection
Clinics Injection
Hydroxyprogesterone Caproate Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hydroxyprogesterone Caproate market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Hydroxyprogesterone Caproate and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hydroxyprogesterone Caproate.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Hydroxyprogesterone Caproate manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Hydroxyprogesterone Caproate by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Hydroxyprogesterone Caproate in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 1 mL Injection(Including 1.1 mL)
- 5 mL Injection
Applications
- Hospitals Injection
- Clinics Injection
Companies covered
- Zhejiang Xianju Pharmaceutical
- Mylan Institutional
- Upjohn Co
- Symbiotec Pharmalab
- Sun Pharmaceutical
- Steroid Spa
- Schering Ag
- Naari Ag
- Mcguff Pharmaceuticals Inc
- Diosynth Bv
- Aspen Oss B.V.
- Antibioticos Spa
- ANI Pharmaceuticals, Inc.
- AMAG Pharmaceuticals
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Hydroxyprogesterone Caproate Market Size (2021-2032)
- 2.2.2 Global Hydroxyprogesterone Caproate Sales (2021-2032)
- 2.2.3 Global Hydroxyprogesterone Caproate Market Average Price (2021-2032)
- 2.3 Hydroxyprogesterone Caproate by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 1 mL Injection(Including 1.1 mL)
- 2.3.3 5 mL Injection
- 2.4 Hydroxyprogesterone Caproate by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospitals Injection
- 2.4.3 Clinics Injection
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Hydroxyprogesterone Caproate Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Hydroxyprogesterone Caproate Sales (W Tons) of Manufacturers (2021-2026)
- 3.3 Global Hydroxyprogesterone Caproate Revenue of Manufacturers (2021-2026)
- 3.4 Global Hydroxyprogesterone Caproate Average Price by Manufacturers (2021-2026)
- 3.5 Global Hydroxyprogesterone Caproate Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Hydroxyprogesterone Caproate, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Hydroxyprogesterone Caproate, Product Type & Application
- 3.8 Global Manufacturers of Hydroxyprogesterone Caproate, Established Date
- 3.9 Global Hydroxyprogesterone Caproate Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Zhejiang Xianju Pharmaceutical
- 4.1.1 Zhejiang Xianju Pharmaceutical Company Information
- 4.1.2 Zhejiang Xianju Pharmaceutical Business Overview
- 4.1.3 Zhejiang Xianju Pharmaceutical Hydroxyprogesterone Caproate Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Zhejiang Xianju Pharmaceutical Hydroxyprogesterone Caproate Product Portfolio
- 4.1.5 Zhejiang Xianju Pharmaceutical Recent Developments
- 4.2 Mylan Institutional
- 4.2.1 Mylan Institutional Company Information
- 4.2.2 Mylan Institutional Business Overview
- 4.2.3 Mylan Institutional Hydroxyprogesterone Caproate Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Mylan Institutional Hydroxyprogesterone Caproate Product Portfolio
- 4.2.5 Mylan Institutional Recent Developments
- 4.3 Upjohn Co
- 4.3.1 Upjohn Co Company Information
- 4.3.2 Upjohn Co Business Overview
- 4.3.3 Upjohn Co Hydroxyprogesterone Caproate Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Upjohn Co Hydroxyprogesterone Caproate Product Portfolio
- 4.3.5 Upjohn Co Recent Developments
- 4.4 Symbiotec Pharmalab
- 4.4.1 Symbiotec Pharmalab Company Information
- 4.4.2 Symbiotec Pharmalab Business Overview
- 4.4.3 Symbiotec Pharmalab Hydroxyprogesterone Caproate Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Symbiotec Pharmalab Hydroxyprogesterone Caproate Product Portfolio
- 4.4.5 Symbiotec Pharmalab Recent Developments
- 4.5 Sun Pharmaceutical
- 4.5.1 Sun Pharmaceutical Company Information
- 4.5.2 Sun Pharmaceutical Business Overview
- 4.5.3 Sun Pharmaceutical Hydroxyprogesterone Caproate Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Sun Pharmaceutical Hydroxyprogesterone Caproate Product Portfolio
- 4.5.5 Sun Pharmaceutical Recent Developments
- 4.6 Steroid Spa
- 4.6.1 Steroid Spa Company Information
- 4.6.2 Steroid Spa Business Overview
- 4.6.3 Steroid Spa Hydroxyprogesterone Caproate Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Steroid Spa Hydroxyprogesterone Caproate Product Portfolio
- 4.6.5 Steroid Spa Recent Developments
- 4.7 Schering Ag
- 4.7.1 Schering Ag Company Information
- 4.7.2 Schering Ag Business Overview
- 4.7.3 Schering Ag Hydroxyprogesterone Caproate Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Schering Ag Hydroxyprogesterone Caproate Product Portfolio
- 4.7.5 Schering Ag Recent Developments
- 4.8 Naari Ag
- 4.8.1 Naari Ag Company Information
- 4.8.2 Naari Ag Business Overview
- 4.8.3 Naari Ag Hydroxyprogesterone Caproate Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Naari Ag Hydroxyprogesterone Caproate Product Portfolio
- 4.8.5 Naari Ag Recent Developments
- 4.9 Mcguff Pharmaceuticals Inc
- 4.9.1 Mcguff Pharmaceuticals Inc Company Information
- 4.9.2 Mcguff Pharmaceuticals Inc Business Overview
- 4.9.3 Mcguff Pharmaceuticals Inc Hydroxyprogesterone Caproate Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Mcguff Pharmaceuticals Inc Hydroxyprogesterone Caproate Product Portfolio
- 4.9.5 Mcguff Pharmaceuticals Inc Recent Developments
- 4.10 Diosynth Bv
- 4.10.1 Diosynth Bv Company Information
- 4.10.2 Diosynth Bv Business Overview
- 4.10.3 Diosynth Bv Hydroxyprogesterone Caproate Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Diosynth Bv Hydroxyprogesterone Caproate Product Portfolio
- 4.10.5 Diosynth Bv Recent Developments
- 4.11 Aspen Oss B.V.
- 4.11.1 Aspen Oss B.V. Company Information
- 4.11.2 Aspen Oss B.V. Business Overview
- 4.11.3 Aspen Oss B.V. Hydroxyprogesterone Caproate Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Aspen Oss B.V. Hydroxyprogesterone Caproate Product Portfolio
- 4.11.5 Aspen Oss B.V. Recent Developments
- 4.12 Antibioticos Spa
- 4.12.1 Antibioticos Spa Company Information
- 4.12.2 Antibioticos Spa Business Overview
- 4.12.3 Antibioticos Spa Hydroxyprogesterone Caproate Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Antibioticos Spa Hydroxyprogesterone Caproate Product Portfolio
- 4.12.5 Antibioticos Spa Recent Developments
- 4.13 ANI Pharmaceuticals, Inc.
- 4.13.1 ANI Pharmaceuticals, Inc. Company Information
- 4.13.2 ANI Pharmaceuticals, Inc. Business Overview
- 4.13.3 ANI Pharmaceuticals, Inc. Hydroxyprogesterone Caproate Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 ANI Pharmaceuticals, Inc. Hydroxyprogesterone Caproate Product Portfolio
- 4.13.5 ANI Pharmaceuticals, Inc. Recent Developments
- 4.14 AMAG Pharmaceuticals
- 4.14.1 AMAG Pharmaceuticals Company Information
- 4.14.2 AMAG Pharmaceuticals Business Overview
- 4.14.3 AMAG Pharmaceuticals Hydroxyprogesterone Caproate Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 AMAG Pharmaceuticals Hydroxyprogesterone Caproate Product Portfolio
- 4.14.5 AMAG Pharmaceuticals Recent Developments
5 Global Hydroxyprogesterone Caproate Market Scenario by Region
- 5.1 Global Hydroxyprogesterone Caproate Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Hydroxyprogesterone Caproate Sales by Region: 2021-2032
- 5.2.1 Global Hydroxyprogesterone Caproate Sales by Region: 2021-2026
- 5.2.2 Global Hydroxyprogesterone Caproate Sales by Region: 2027-2032
- 5.3 Global Hydroxyprogesterone Caproate Revenue by Region: 2021-2032
- 5.3.1 Global Hydroxyprogesterone Caproate Revenue by Region: 2021-2026
- 5.3.2 Global Hydroxyprogesterone Caproate Revenue by Region: 2027-2032
- 5.4 North America Hydroxyprogesterone Caproate Market Facts & Figures by Country
- 5.4.1 North America Hydroxyprogesterone Caproate Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Hydroxyprogesterone Caproate Sales by Country (2021-2032)
- 5.4.3 North America Hydroxyprogesterone Caproate Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Hydroxyprogesterone Caproate Market Facts & Figures by Country
- 5.5.1 Europe Hydroxyprogesterone Caproate Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Hydroxyprogesterone Caproate Sales by Country (2021-2032)
- 5.5.3 Europe Hydroxyprogesterone Caproate Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Hydroxyprogesterone Caproate Market Facts & Figures by Country
- 5.6.1 Asia Pacific Hydroxyprogesterone Caproate Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Hydroxyprogesterone Caproate Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Hydroxyprogesterone Caproate Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Hydroxyprogesterone Caproate Market Facts & Figures by Country
- 5.7.1 South America Hydroxyprogesterone Caproate Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Hydroxyprogesterone Caproate Sales by Country (2021-2032)
- 5.7.3 South America Hydroxyprogesterone Caproate Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Hydroxyprogesterone Caproate Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Hydroxyprogesterone Caproate Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Hydroxyprogesterone Caproate Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Hydroxyprogesterone Caproate Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Hydroxyprogesterone Caproate Sales by Type (2021-2032)
- 6.1.1 Global Hydroxyprogesterone Caproate Sales by Type (2021-2032) & (W Tons)
- 6.1.2 Global Hydroxyprogesterone Caproate Sales Market Share by Type (2021-2032)
- 6.2 Global Hydroxyprogesterone Caproate Revenue by Type (2021-2032)
- 6.2.1 Global Hydroxyprogesterone Caproate Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Hydroxyprogesterone Caproate Revenue Market Share by Type (2021-2032)
- 6.3 Global Hydroxyprogesterone Caproate Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Hydroxyprogesterone Caproate Sales by Application (2021-2032)
- 7.1.1 Global Hydroxyprogesterone Caproate Sales by Application (2021-2032) & (W Tons)
- 7.1.2 Global Hydroxyprogesterone Caproate Sales Market Share by Application (2021-2032)
- 7.2 Global Hydroxyprogesterone Caproate Revenue by Application (2021-2032)
- 7.2.1 Global Hydroxyprogesterone Caproate Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Hydroxyprogesterone Caproate Revenue Market Share by Application (2021-2032)
- 7.3 Global Hydroxyprogesterone Caproate Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Hydroxyprogesterone Caproate Value Chain Analysis
- 8.1.1 Hydroxyprogesterone Caproate Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Hydroxyprogesterone Caproate Production Mode & Process
- 8.2 Hydroxyprogesterone Caproate Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Hydroxyprogesterone Caproate Distributors
- 8.2.3 Hydroxyprogesterone Caproate Customers
9 Global Hydroxyprogesterone Caproate Analyzing Market Dynamics
- 9.1 Hydroxyprogesterone Caproate Industry Trends
- 9.2 Hydroxyprogesterone Caproate Industry Drivers
- 9.3 Hydroxyprogesterone Caproate Industry Opportunities and Challenges
- 9.4 Hydroxyprogesterone Caproate Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst